Health experts, gathering at the U.N., have begun to shift their focus to try to provide access to basic drugs in countries where preventable deaths from infections occur too frequently.
Tag: Lancet, The (Journal)
The Global Threat of Antibiotic Resistance
International health experts have begun to shift their focus to try to provide access to basic drugs in countries where preventable deaths from infections occur too frequently.
Letter in The Lancet Raises Question of Excess Deaths in Gaza War
A letter in a major medical journal has prompted a discussion about the importance, and difficulty, of tallying those killed as an indirect result of the conflict between Israel and Hamas.
Lancet Countdown Report Shows Climate Change’s Impact on Health
The 8th update to a major international report shows more people are getting sick and dying from extreme heat, drought and other climate problems.
Mpox Often Leads to Severe Illness, Even Death, in People With Advanced H.I.V.
The death rate among these patients is about 15 percent, researchers reported. The virus should be added to the list of opportunistic infections seen in patients with advanced H.I.V., scientists said.
In Women and Nonbinary People, Monkeypox Cases May Have Been Missed
Despite monkeypox fading from public attention, scientists are still learning how it spreads — including without sexual contact or any symptoms.
Can the Olympics Take the Heat?
Plus: squirrel acrobats, gecko navigators, hair thieves and other natural overachievers in the Friday edition of the Science Times newsletter.
More than 1.5 million children have lost a caregiver to the pandemic, a study says.
The number of children in need is only expected to grow as Covid-19 cases rise in areas short of vaccines and as variants spread.
Severe Covid Is More Often Fatal in Africa Than in Other Regions
Inadequate treatment for critically ill patients contributed to higher death rates in Africa, compared to other parts of the world, a study found.
Pfizer Vaccine Is Highly Effective Against Variants, Studies Find
Two studies showed the vaccine to be more than 95 percent effective at protecting against severe disease or death from the variants first identified in South Africa and the U.K.